Apollomics (APLM) Enterprise Value (2020 - 2025)
Apollomics (APLM) reported Enterprise Value of -$3.3 million for Q4 2025, up 43.13% quarter-over-quarter from -$5.8 million in Q4 2023.
Apollomics (APLM) Enterprise Value (2020 - 2025) Analysis & Trends
Apollomics (APLM) has 5 years of Enterprise Value data on file, last reported at -$3.3 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$3.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.3 million (changed N/A YoY), and the FY2025 annual result was -$3.3 million, changed N/A from the prior year.
- Enterprise Value climbed to -$3.3 million in Q4 2025 per APLM's latest filing, from -$5.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$3.3 million in Q4 2025 and troughed at -$51.7 million in Q4 2022.
- A 4-year average of -$23.3 million and a median of -$25.3 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value plunged 71.16% in 2022, then jumped 88.87% in 2023.
- A 4-year view of Enterprise Value shows it stood at -$30.2 million in 2021, then sank by 71.16% to -$51.7 million in 2022, then jumped by 88.87% to -$5.8 million in 2023, then soared by 43.13% to -$3.3 million in 2025.
- Business Quant data shows APLM's Enterprise Value at -$3.3 million in Q4 2025, -$5.8 million in Q4 2023, and -$25.3 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | -3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.28 Mn |
| Dec 31, 2023 | -5.76 Mn |
| Jun 30, 2023 | -25.30 Mn |
| Dec 31, 2022 | -51.74 Mn |
| Dec 31, 2021 | -30.23 Mn |
| Dec 31, 2020 | -130.65 Mn |